We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.03%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$33.1B
AUM Growth
+$1.62B
(+5.1%)
Cap. Flow
+$885M
Cap. Flow
% of AUM
2.67%
Top 10 Holdings %
Top 10 Hldgs %
37%
Holding
1,568
New
69
Increased
691
Reduced
367
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$864M |
| 2 |
Bank of America
BAC
|
+$84.7M |
| 3 |
Edwards Lifesciences
EW
|
+$69M |
| 4 |
Alibaba
BABA
|
+$65.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$56.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$83.9M |
| 2 |
Tyler Technologies
TYL
|
+$73.9M |
| 3 |
Core & Main
CNM
|
+$73M |
| 4 |
Itron
ITRI
|
+$71.3M |
| 5 |
Uber
UBER
|
+$70.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 12.06% |
| 4 | Communication Services | 11.11% |
| 5 | Consumer Discretionary | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Interparfums
IPAR
$3.7B
| $747K | ﹤0.01% |
8,800
-200
| -2% | -$17.6K |
|
1177
Liberty Global Class A
LBTYA
$3.58B
| $741K | ﹤0.01% |
66,533
+29,833
| +81% | +$330K |
|
1178
Independent Bank
INDB
$4.05B
| $740K | ﹤0.01% |
10,129
| – | – |
|
1179
Teradata
TDC
$2.57B
| $737K | ﹤0.01% |
24,204
| – | – |
|
|
CON
1180
Concentra Group Holdings
CON
$4.48B
| $732K | ﹤0.01% |
37,172
+2,200
| +6% | +$44K |
|
1181
Tenable Holdings
TENB
$4.41B
| $729K | ﹤0.01% |
31,000
| – | – |
|
1182
Denali Therapeutics
DNLI
$3.97B
| $723K | ﹤0.01% |
43,800
+5,500
| +14% | +$92.8K |
|
1183
Globant
GLOB
$1.77B
| $713K | ﹤0.01% |
10,900
| – | – |
|
|
SLNO
1184
DELISTED
Soleno Therapeutics
SLNO
| $713K | ﹤0.01% |
15,400
+1,600
| +12% | +$87.7K |
|
1185
InvenTrust Properties
IVT
$2.62B
| $711K | ﹤0.01% |
25,200
| – | – |
|
1186
UFP Technologies
UFPT
$2.48B
| $710K | ﹤0.01% |
3,200
+1,000
| +45% | +$214K |
|
1187
Unifirst Corp
UNF
$5.21B
| $710K | ﹤0.01% |
3,679
| – | – |
|
1188
Life Time Group Holdings
LTH
$9.9B
| $707K | ﹤0.01% |
26,600
+6,000
| +29% | +$156K |
|
1189
Credit Acceptance
CACC
$6.05B
| $703K | ﹤0.01% |
1,586
| – | – |
|
1190
Celldex Therapeutics
CLDX
$3.35B
| $703K | ﹤0.01% |
25,900
+4,300
| +20% | +$113K |
|
1191
HNI Corp
HNI
$3.56B
| $703K | ﹤0.01% |
16,716
+5,790
| +53% | +$245K |
|
1192
Choice Hotels
CHH
$4.71B
| $700K | ﹤0.01% |
7,351
| – | – |
|
1193
QuidelOrtho
QDEL
$1.03B
| $697K | ﹤0.01% |
24,419
+5,900
| +32% | +$160K |
|
1194
Extreme Networks
EXTR
$3.16B
| $694K | ﹤0.01% |
41,700
| – | – |
|
1195
Marriott Vacations Worldwide
VAC
$4.17B
| $691K | ﹤0.01% |
11,977
+500
| +4% | +$29.6K |
|
1196
Brady Corp
BRC
$4.43B
| $690K | ﹤0.01% |
8,809
+2,000
| +29% | +$155K |
|
1197
GeneDx Holdings
WGS
$2.36B
| $689K | ﹤0.01% |
5,300
-300
| -5% | -$41.2K |
|
1198
Revolve Group
RVLV
$1.72B
| $688K | ﹤0.01% |
22,800
+6,600
| +41% | +$159K |
|
1199
Nelnet
NNI
$4.55B
| $685K | ﹤0.01% |
5,151
+800
| +18% | +$105K |
|
|
CURB
1200
Curbline Properties
CURB
$3.46B
| $682K | ﹤0.01% |
29,400
+3,900
| +15% | +$90.9K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2025 Portfolio in Review
As of Q4 2025, Handelsbanken Fonder held 1,568 positions worth $33.1B, up 5.1% from $31.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Handelsbanken Fonder's Q4 2025 filing shows 69 new, 691 increased, 367 reduced and 73 closed positions. Its largest new stake was Fluence Energy: 857,654 shares worth $17M. The largest sale was Eli Lilly, an estimated $83.9M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Financials.
- Handelsbanken Fonder's largest Q4 2025 buy was Fluence Energy: 857,654 shares worth $17M.
- Handelsbanken Fonder added most to Amazon in Q4 2025, an estimated $864M increase.
- Handelsbanken Fonder's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $83.9M.
- Handelsbanken Fonder fully exited Kellanova in Q4 2025, selling an estimated $26M.
- Handelsbanken Fonder's ten largest holdings make up 37% of its $33.1B portfolio in Q4 2025.
- Handelsbanken Fonder opened 69 new positions and closed 73 in Q4 2025.
- Handelsbanken Fonder's portfolio value rose 5.1% quarter-over-quarter to $33.1B.
Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.